about
Brimonidine in the treatment of glaucoma and ocular hypertensionThe current research status of normal tension glaucomaNeuroprotection for treatment of glaucoma in adultsNeuroprotection for treatment of glaucoma in adultsNeuroprotection for prevention and treatment of glaucoma in adultsCytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesEnhancement of scleral macromolecular permeability with prostaglandinsNeuroprotection for treatment of glaucoma in adults.Simultaneous expression of c-Jun and p53 in retinal ganglion cells of adult rat retinal slice cultures.Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucomaThe bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype.Female reproductive factors and open angle glaucoma: the Blue Mountains Eye StudyGenotype and phenotype correlations in congenital glaucoma.Glaucoma medications: use and safety in the elderly population.Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucomaFixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.Medical treatment of glaucoma: present and future.Glaucomatous optic neuropathy management: the role of neuroprotective agents.Current Concepts in the Biochemical Mechanisms of Glaucomatous Neurodegeneration.Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model.Edible seaweed, Eisenia bicyclis, protects retinal ganglion cells death caused by oxidative stress.Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension.Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma.Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy.Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.Translational Pharmacology in Glaucoma Neuroprotection.
P2860
Q22305848-9CED1C0D-4B7C-4965-8BDA-BD6F45774E84Q22305862-B705731C-B0BA-40FA-A5BF-3F1FB3CAA9DDQ24200657-32E6846F-6447-4EFB-94CA-23CF814ACEC9Q24240024-17FA2CB9-C409-40DA-A1A1-9F9D1B1B2971Q24245944-30F971A1-D607-4B0B-B30F-AFE4C9A7C050Q26775083-EDC7CE8F-B5D7-4DF7-A968-DBA264E2FFEFQ28345276-7B052389-FFD1-48F8-91DC-E26B31C31FC7Q30238789-246C44DB-79A0-497F-A593-7EFD1ABB896EQ30843997-9218EBF1-BC48-4A92-A0F7-F28B45731B76Q34734517-88FA2116-BB52-48D1-BAD1-236268BF0ECFQ35221061-44E25446-9426-48E3-8973-C1A861861709Q35591524-721DB534-1624-41D9-8DA0-5A8E6945BF1EQ35662580-9885B3C6-EA8F-4EB6-9954-DFD5302011A7Q36491778-50D6760C-5FD3-490A-9CE6-6AE8A6F34401Q37187224-97C97B6B-B70C-4944-90B9-7FACB9FD92D8Q37716010-073C8C62-C994-4D4C-849B-841DF5BF7FDDQ37870933-0F41A2FC-8F61-4193-A0EE-50E331411162Q38193827-81C2CA7F-92EA-4FCB-90E8-F533F4ED45C3Q38258778-500F5B2E-15EA-4063-8356-A4CE871CEE85Q38663505-64CC0673-1106-4CEA-861C-36EDCB927F13Q39345466-7F09C322-7DEA-44B4-9B1B-1A4E07E92035Q39401937-3514FE9D-D283-47BA-89EA-CDD6DFF1ED87Q42075577-42B5C171-0131-47EB-8D1C-5AE3983E8D3EQ42142038-5483DACC-08F2-409F-9030-3947D0112761Q46799587-2077F6B2-AD8F-4424-A98E-EF869D1E7022Q46803003-C40AC061-1D80-4DEC-B911-28B4881E9872Q46921491-844D20FB-94A9-47CB-BDFC-3E4A84575062Q53842256-8C3A5BF0-A75C-4082-A004-D1C242ABE06E
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Is neuroprotection a viable therapy for glaucoma?
@ast
Is neuroprotection a viable therapy for glaucoma?
@en
type
label
Is neuroprotection a viable therapy for glaucoma?
@ast
Is neuroprotection a viable therapy for glaucoma?
@en
prefLabel
Is neuroprotection a viable therapy for glaucoma?
@ast
Is neuroprotection a viable therapy for glaucoma?
@en
P1433
P1476
Is neuroprotection a viable therapy for glaucoma?
@en
P2093
R N Weinreb
P304
P356
10.1001/ARCHOPHT.117.11.1540
P407
P577
1999-11-01T00:00:00Z